Danaher Beats Q3 2025 Earnings Expectations

Danaher Corporation (NYSE: DHR) exceeded market expectations in its third quarter of 2025, reporting strong revenue growth and earnings fueled by successful strategic execution. The company’s adjusted diluted net earnings per share reached $1.89, surpassing the anticipated $1.71. This robust performance is attributed to effective execution across key business segments and the continued success of the bioprocessing and respiratory healthcare divisions.